Type | Drug | Route | Prophylactic dose | Observed in sample |
---|---|---|---|---|
Heparin | Heparin | SC | 5000 units b.i.d. or t.i.d. | 1094 (30.2%) |
LMWH | Enoxaparin | SC | 40 mg q.d. or 30 mg b.i.d. | 2506 (69.1%) |
LMWH | Fondaparinux | SC | 2.5 mg q.d. | 4 (0.1%) |
LMWH | Dalteparin | SC | 2500–5000 units q.d. | - |
DOAC | Apixaban | Oral | 2.5 mg b.i.d. | 21 (0.6%) |
DOAC | Rivaroxaban | Oral | 10 mg q.d. or 2.5 mg b.i.d. for arterial disease | 2 (0.1%) |
DOAC | Dabigatran | Oral | 220 mg q.d. | - |
Abbreviations: q.d., once daily; b.i.d., twice daily; t.i.d., thrice daily; SC, subcutaneous; LMWH, low-molecular-weight heparin; DOAC, direct oral anticoagulant